AKT1 and metabolic dysfunction-associated steatotic liver disease: After ICV injection of [D-Lys-3]-GHRP-6, the expression levels of p-PI3K, p-Akt, and p-mTOR in the hypothalamus increased significantly (n=10, compared with the NAFLD group, P<0.01, Figure 6).